{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T18:58:25Z","timestamp":1778698705507,"version":"3.51.4"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,19]],"date-time":"2024-02-19T00:00:00Z","timestamp":1708300800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002873","name":"Chulalongkorn University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002873","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001801","name":"University of Western Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001801","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.eclinm.2024.102517","type":"journal-article","created":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T16:55:31Z","timestamp":1710435331000},"page":"102517","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Early treatment with fluvoxamine, bromhexine, cyproheptadine, and niclosamide to prevent clinical deterioration in patients with symptomatic COVID-19: a randomized clinical trial"],"prefix":"10.1016","volume":"70","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6316-1221","authenticated-orcid":false,"given":"Dhammika Leshan","family":"Wannigama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cameron","family":"Hurst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phatthranit","family":"Phattharapornjaroen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parichart","family":"Hongsing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natchalaikorn","family":"Sirichumroonwit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanokpoj","family":"Chanpiwat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali Hosseini","family":"Rad S.M.","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin James","family":"Storer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Puey","family":"Ounjai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phitsanuruk","family":"Kanthawee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9569-396X","authenticated-orcid":false,"given":"Natharin","family":"Ngamwongsatit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosalyn","family":"Kupwiwat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaisit","family":"Kupwiwat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2074-8262","authenticated-orcid":false,"given":"James Michael","family":"Brimson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naveen Kumar","family":"Devanga Ragupathi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Somrat","family":"Charuluxananan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asada","family":"Leelahavanichkul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Talerngsak","family":"Kanjanabuch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8677-9454","authenticated-orcid":false,"given":"Paul G.","family":"Higgins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6433-2691","authenticated-orcid":false,"given":"Vishnu Nayak","family":"Badavath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3509-3433","authenticated-orcid":false,"given":"Mohan","family":"Amarasiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valerie","family":"Verhasselt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0008-9733","authenticated-orcid":false,"given":"Anthony","family":"Kicic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanittha","family":"Chatsuwan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kashif","family":"Pirzada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farid","family":"Jalali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3203-4590","authenticated-orcid":false,"given":"Angela M.","family":"Reiersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuichi","family":"Abe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chanikan","family":"Tanasatitchai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Supamat","family":"Amphol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ladda","family":"Nantawong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prangrawee","family":"Sangchan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Varissara","family":"Sinkajarern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thutpharritchn","family":"Phoonakh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phornnapat","family":"Utenpattanun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aye Mya","family":"Sithu Shein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timporn","family":"Vitoonpong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nichapha","family":"Chongthavonsatit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yahya","family":"Mankong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piyapong","family":"Chaichana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenjira","family":"Yaithet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dumrongsak","family":"Pongprajak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sukjai","family":"Traimuangpak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gasit","family":"Saksirisampant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phimonsiri","family":"Lamloeskittinon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam Adam","family":"Hamdy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sinthu Sinthu","family":"Kosasih","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sirirat Sirirat","family":"Luk-in","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.eclinm.2024.102517_bib1","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/s41591-020-0968-3","article-title":"Extrapulmonary manifestations of COVID-19","volume":"26","author":"Gupta","year":"2020","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.eclinm.2024.102517_bib2","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41579-020-00459-7","article-title":"Characteristics of SARS-CoV-2 and COVID-19","volume":"19","author":"Hu","year":"2021","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.eclinm.2024.102517_bib3","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1017\/S0950268822000139","article-title":"Return to normal pre-COVID-19 life is delayed by inequitable vaccine allocation and SARS-CoV-2 variants","volume":"150","author":"Liu","year":"2022","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.eclinm.2024.102517_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.107019","article-title":"COVID-19 monitoring with sparse sampling of sewered and non-sewered wastewater in urban and rural communities","volume":"26","author":"Wannigama","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.eclinm.2024.102517_bib5","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.ijid.2021.05.005","article-title":"Tracking COVID-19 with wastewater to understand asymptomatic transmission","volume":"108","author":"Wannigama","year":"2021","journal-title":"Int J Infect Dis"},{"issue":"4","key":"10.1016\/j.eclinm.2024.102517_bib6","first-page":"1177","article-title":"Modeling vaccination strategies with limited early COVID-19 vaccine access in low- and middle-income countries: a case study of Thailand","volume":"8","author":"Anupong","year":"2023","journal-title":"Infect Dis Model"},{"issue":"4","key":"10.1016\/j.eclinm.2024.102517_bib7","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/s41591-022-01699-1","article-title":"Effectiveness of COVID-19 booster vaccines against COVID-19-related symptoms, hospitalization and death in England","volume":"28","author":"Andrews","year":"2022","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102517_bib8","doi-asserted-by":"crossref","first-page":"5736","DOI":"10.1038\/s41467-022-33378-7","article-title":"Effectiveness of COVID-19 vaccines against Omicron and Delta hospitalisation, a test negative case-control study","volume":"13","author":"Stowe","year":"2022","journal-title":"Nat Commun"},{"issue":"10331","key":"10.1016\/j.eclinm.2024.102517_bib9","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/S0140-6736(22)00194-5","article-title":"Evaluating COVID-19 vaccines in the real world","volume":"399","author":"Mills","year":"2022","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.eclinm.2024.102517_bib10","doi-asserted-by":"crossref","first-page":"e464","DOI":"10.1016\/S1473-3099(23)00620-5","article-title":"Tracing the new SARS-CoV-2 variant BA.2.86 in the community through wastewater surveillance in Bangkok, Thailand","volume":"23","author":"Wannigama","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.eclinm.2024.102517_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.109043","article-title":"Exploring indoor and outdoor dust as a potential tool for detection and monitoring of COVID-19 transmission","volume":"27","author":"Anupong","year":"2024","journal-title":"iScience"},{"key":"10.1016\/j.eclinm.2024.102517_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.652688","article-title":"Fluvoxamine: a review of its mechanism of action and its role in COVID-19","volume":"12","author":"Sukhatme","year":"2021","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102517_bib13","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-44219-y","article-title":"The impact of non-synonymous mutations on miRNA binding sites within the SARS-CoV-2 NSP3 and NSP4 genes","volume":"13","author":"Rad","year":"2023","journal-title":"Sci Rep"},{"issue":"22","key":"10.1016\/j.eclinm.2024.102517_bib14","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1001\/jama.2020.22760","article-title":"Fluvoxamine vs placebo and clinical deterioration in outpatients with symptomatic COVID-19: a randomized clinical trial","volume":"324","author":"Lenze","year":"2020","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.eclinm.2024.102517_bib15","doi-asserted-by":"crossref","first-page":"e226269","DOI":"10.1001\/jamanetworkopen.2022.6269","article-title":"Fluvoxamine for outpatient management of COVID-19 to prevent hospitalization: a systematic review and meta-analysis","volume":"5","author":"Lee","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102517_bib16","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1016\/S2214-109X(21)00448-4","article-title":"Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial","volume":"10","author":"Reis","year":"2022","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.eclinm.2024.102517_bib17","article-title":"Efficacy of fluvoxamine in outpatients with COVID-19: understanding conflicting conclusions from 2 recent meta-analyses of the same clinical trials","author":"S\u00e1nchez-Rico","year":"2023","journal-title":"Ann Pharmacother"},{"issue":"6","key":"10.1016\/j.eclinm.2024.102517_bib18","article-title":"The IL-1\u03b2, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19","volume":"3","author":"Schulthei\u00df","year":"2022","journal-title":"Cell Rep Med"},{"issue":"3","key":"10.1016\/j.eclinm.2024.102517_bib19","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.20com13373","article-title":"\"What were you before the war?\" Repurposing psychiatry during the COVID-19 pandemic","volume":"81","author":"Nicol","year":"2020","journal-title":"J\u00a0Clin Psychiatry"},{"issue":"6521","key":"10.1016\/j.eclinm.2024.102517_bib20","doi-asserted-by":"crossref","DOI":"10.1126\/science.abe9403","article-title":"Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms","volume":"370","author":"Gordon","year":"2020","journal-title":"Science"},{"issue":"7816","key":"10.1016\/j.eclinm.2024.102517_bib21","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/s41586-020-2286-9","article-title":"A\u00a0SARS-CoV-2 protein interaction map reveals targets for drug repurposing","volume":"583","author":"Gordon","year":"2020","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.eclinm.2024.102517_bib22","doi-asserted-by":"crossref","first-page":"7098","DOI":"10.1038\/s41380-021-01254-3","article-title":"Repurposing antidepressants inhibiting the sphingomyelinase acid\/ceramide system against COVID-19: current evidence and potential mechanisms","volume":"26","author":"Hoertel","year":"2021","journal-title":"Mol Psychiatry"},{"issue":"4","key":"10.1016\/j.eclinm.2024.102517_bib23","doi-asserted-by":"crossref","first-page":"209","DOI":"10.34172\/bi.2020.27","article-title":"Effect of bromhexine on clinical outcomes and mortality in COVID-19 patients: a randomized clinical trial","volume":"10","author":"Ansarin","year":"2020","journal-title":"Bioimpacts"},{"key":"10.1016\/j.eclinm.2024.102517_bib24","article-title":"In\u00a0vitro inhibition of SARS-CoV-2 infection by bromhexine hydrochloride","author":"Martins","year":"2022","journal-title":"bioRxiv"},{"issue":"4","key":"10.1016\/j.eclinm.2024.102517_bib25","doi-asserted-by":"crossref","DOI":"10.14309\/crj.0000000000001034","article-title":"Cyproheptadine treatment of COVID-19-induced enteritis: implications for hyperinflammatory phase management","volume":"10","author":"Weinstock","year":"2023","journal-title":"ACG Case Rep J"},{"issue":"12","key":"10.1016\/j.eclinm.2024.102517_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0260958","article-title":"Niclosamide shows strong antiviral activity in a human airway model of SARS-CoV-2 infection and a conserved potency against the Alpha (B.1.1.7), Beta (B.1.351) and Delta variant (B.1.617.2)","volume":"16","author":"Weiss","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.eclinm.2024.102517_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.amsu.2021.102779","article-title":"A\u00a0randomised controlled trial of effectiveness and safety of Niclosamide as add on therapy to the standard of care measures in COVID-19 management","volume":"69","author":"Abdulamir","year":"2021","journal-title":"Ann Med Surg"},{"issue":"10","key":"10.1016\/j.eclinm.2024.102517_bib28","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.eng.2020.03.007","article-title":"Experimental treatment with favipiravir for COVID-19: an open-label control study","volume":"6","author":"Cai","year":"2020","journal-title":"Engineering"},{"key":"10.1016\/j.eclinm.2024.102517_bib29","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/5859729","article-title":"A\u00a0systematic review and meta-analysis estimating the expected dropout rates in randomized controlled trials on yoga interventions","volume":"2016","author":"Cramer","year":"2016","journal-title":"Evid Based Complement Alternat Med"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102517_bib30","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1080\/07853890.2022.2034936","article-title":"Efficacy and safety of three new oral antiviral treatment (molnupiravir, fluvoxamine and Paxlovid) for COVID-19:a meta-analysis","volume":"54","author":"Wen","year":"2022","journal-title":"Ann Med"},{"issue":"2","key":"10.1016\/j.eclinm.2024.102517_bib31","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofab050","article-title":"Prospective cohort of fluvoxamine for early treatment of coronavirus disease 19","volume":"8","author":"Seftel","year":"2021","journal-title":"Open Forum Infect Dis"},{"issue":"9","key":"10.1016\/j.eclinm.2024.102517_bib32","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1007\/s40262-022-01154-x","article-title":"Could fluvoxamine dose de-escalation increase treatment compliance without sacrificing efficacy in COVID-19 patients?","volume":"61","author":"Marcec","year":"2022","journal-title":"Clin Pharmacokinet"},{"issue":"3","key":"10.1016\/j.eclinm.2024.102517_bib33","doi-asserted-by":"crossref","first-page":"e332","DOI":"10.1016\/S2214-109X(22)00006-7","article-title":"Fluvoxamine for the treatment of COVID-19","volume":"10","author":"Dodds","year":"2022","journal-title":"Lancet Global Health"},{"issue":"8","key":"10.1016\/j.eclinm.2024.102517_bib34","doi-asserted-by":"crossref","first-page":"ofad419","DOI":"10.1093\/ofid\/ofad419","article-title":"The STOP COVID 2 study: fluvoxamine vs placebo for outpatients with symptomatic COVID-19, a fully remote randomized controlled trial","volume":"10","author":"Reiersen","year":"2023","journal-title":"Open Forum Infect Dis"},{"issue":"24","key":"10.1016\/j.eclinm.2024.102517_bib35","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1001\/jama.2023.23363","article-title":"Higher-dose fluvoxamine and time to sustained recovery in outpatients with COVID-19: the ACTIV-6 randomized clinical trial","volume":"330","author":"Stewart","year":"2023","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102517_bib36","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s44192-023-00036-3","article-title":"Overview of the potential use of fluvoxamine for COVID-19 and long COVID","volume":"3","author":"Hashimoto","year":"2023","journal-title":"Discov Ment Health"},{"key":"10.1016\/j.eclinm.2024.102517_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.101019","article-title":"Characterizing long COVID in an international cohort: 7 months of symptoms and their impact","volume":"38","author":"Davis","year":"2021","journal-title":"eClinicalMedicine"},{"issue":"2","key":"10.1016\/j.eclinm.2024.102517_bib38","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1145\/6497.214326","article-title":"Algorithm 643: fexact: a FORTRAN subroutine for Fisher's exact test on unordered r\u00d7c contingency tables","volume":"12","author":"Mehta","year":"1986","journal-title":"ACM Trans Math Softw"},{"issue":"4","key":"10.1016\/j.eclinm.2024.102517_bib39","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1145\/168173.168412","article-title":"A\u00a0remark on algorithm 643: fexact: an algorithm for performing Fisher's exact test in r x c contingency tables","volume":"19","author":"Clarkson","year":"1993","journal-title":"ACM Trans Math Softw"},{"issue":"2","key":"10.1016\/j.eclinm.2024.102517_bib40","first-page":"65","article-title":"A\u00a0simple sequentially rejective multiple test procedure","volume":"6","author":"Holm","year":"1979","journal-title":"Scand J Stat"},{"key":"10.1016\/j.eclinm.2024.102517_bib41","series-title":"R: a language and environment for statistical computing","author":"Team RC","year":"2021"},{"key":"10.1016\/j.eclinm.2024.102517_bib42","series-title":"Nlme: linear and nonlinear mixed effects models","author":"Pinheiro","year":"2023"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102517_bib43","doi-asserted-by":"crossref","first-page":"6571","DOI":"10.1038\/s41467-021-26513-3","article-title":"Burdens of post-acute sequelae of COVID-19 by severity of acute infection, demographics and health status","volume":"12","author":"Xie","year":"2021","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.eclinm.2024.102517_bib44","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41579-022-00846-2","article-title":"Long COVID: major findings, mechanisms and recommendations","volume":"21","author":"Davis","year":"2023","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.eclinm.2024.102517_bib45","article-title":"Profiling post-COVID syndrome across different variants of SARS-CoV-2","author":"Canas","year":"2022","journal-title":"medRxiv"},{"issue":"23","key":"10.1016\/j.eclinm.2024.102517_bib46","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph192315499","article-title":"Brain fog and fatigue following COVID-19 infection: an exploratory study of patient experiences of long COVID","volume":"19","author":"Chasco","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.eclinm.2024.102517_bib47","doi-asserted-by":"crossref","DOI":"10.1038\/s41380-023-02161-5","article-title":"Detrimental effects of COVID-19 in the brain and therapeutic options for long COVID: the role of Epstein-Barr virus and the gut-brain axis","author":"Hashimoto","year":"2023","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.eclinm.2024.102517_bib48","article-title":"Assessing the effect of selective serotonin reuptake inhibitors in the prevention of post-acute sequelae of COVID-19","author":"Sidky","year":"2023","journal-title":"medRxiv"},{"issue":"22","key":"10.1016\/j.eclinm.2024.102517_bib49","doi-asserted-by":"crossref","first-page":"4851","DOI":"10.1016\/j.cell.2023.09.013","article-title":"Serotonin reduction in post-acute sequelae of viral infection","volume":"186","author":"Wong","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.eclinm.2024.102517_bib50","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.86002","article-title":"Pathogenic mechanisms of post-acute sequelae of SARS-CoV-2 infection (PASC)","volume":"12","author":"Sherif","year":"2023","journal-title":"Elife"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102517_bib51","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s40249-023-01086-z","article-title":"Increased interleukin-6 is associated with long COVID-19: a systematic review and meta-analysis","volume":"12","author":"Yin","year":"2023","journal-title":"Infect Dis Poverty"},{"issue":"suppl 8","key":"10.1016\/j.eclinm.2024.102517_bib52","first-page":"104","article-title":"Effect of bromhexine among COVID-19 patients - a meta-anaylsis","volume":"8","author":"Cuerdo","year":"2022","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.eclinm.2024.102517_bib53","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/4693121","article-title":"Bromhexine hydrochloride prophylaxis of COVID-19 for medical personnel: a randomized open-label study","volume":"2022","author":"Mikhaylov","year":"2022","journal-title":"Interdiscip Perspect Infect Dis"},{"key":"10.1016\/j.eclinm.2024.102517_bib54","doi-asserted-by":"crossref","first-page":"100094","DOI":"10.1016\/j.lanepe.2021.100094","article-title":"Getting hands on a drug for Covid-19: inhaled and intranasal niclosamide","volume":"4","author":"Kunzelmann","year":"2021","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.eclinm.2024.102517_bib55","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ijid.2020.09.1429","article-title":"NOD2-dependent BCG-induced trained immunity: a way to regulate innate responses to SARS-CoV2?","volume":"101","author":"Wannigama","year":"2020","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.eclinm.2024.102517_bib56","doi-asserted-by":"crossref","DOI":"10.2139\/ssrn.3800402","article-title":"COVID-19 pathophysiology: are platelets and serotonin hiding in plain sight?","author":"Jalali","year":"2021","journal-title":"SSRN Electron J"},{"issue":"5","key":"10.1016\/j.eclinm.2024.102517_bib57","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.cmi.2023.01.010","article-title":"Efficacy and safety of selective serotonin reuptake inhibitors in COVID-19 management: a systematic review and meta-analysis","volume":"29","author":"Deng","year":"2023","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"10.1016\/j.eclinm.2024.102517_bib58","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1182\/bloodadvances.2020003513","article-title":"Platelet reactivity to thrombin differs between patients with COVID-19 and those with ARDS unrelated to COVID-19","volume":"5","author":"Zaid","year":"2021","journal-title":"Blood Adv"},{"issue":"23","key":"10.1016\/j.eclinm.2024.102517_bib59","doi-asserted-by":"crossref","first-page":"4817","DOI":"10.1182\/bloodadvances.2021004336","article-title":"Platelet Fc\u03b3RIIA-induced serotonin release exacerbates the severity of transfusion-related acute lung injury in mice","volume":"5","author":"El Mdawar","year":"2021","journal-title":"Blood Adv"},{"issue":"8","key":"10.1016\/j.eclinm.2024.102517_bib60","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1055\/a-2072-0366","article-title":"Low \u03b1-thrombin\/GPIb\u03b1 interaction is a potential contributor to platelet hyper-reactivity in COVID-19 patients","volume":"123","author":"Zaid","year":"2023","journal-title":"Thromb Haemost"},{"issue":"10","key":"10.1016\/j.eclinm.2024.102517_bib61","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/s41577-022-00762-9","article-title":"Understanding COVID-19-associated coagulopathy","volume":"22","author":"Conway","year":"2022","journal-title":"Nat Rev Immunol"},{"issue":"7","key":"10.1016\/j.eclinm.2024.102517_bib62","doi-asserted-by":"crossref","first-page":"E1550","DOI":"10.1073\/pnas.1720553115","article-title":"Platelets release pathogenic serotonin and return to circulation after immune complex-mediated sequestration","volume":"115","author":"Cloutier","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"19","key":"10.1016\/j.eclinm.2024.102517_bib63","first-page":"5882","article-title":"Antidepressant use and its association with 28-day mortality in inpatients with SARS-CoV-2: support for the FIASMA model against COVID-19","volume":"11","author":"Hoertel","year":"2022","journal-title":"J\u00a0Clin Med"},{"issue":"7","key":"10.1016\/j.eclinm.2024.102517_bib64","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/s41374-021-00593-7","article-title":"Serotonin-induced vascular permeability is mediated by transient receptor potential vanilloid 4 in the airways and upper gastrointestinal tract of mice","volume":"101","author":"Retamal","year":"2021","journal-title":"Lab Invest"},{"issue":"10","key":"10.1016\/j.eclinm.2024.102517_bib65","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0267423","article-title":"The effect of antidepressants on the severity of COVID-19 in hospitalized patients: a systematic review and meta-analysis","volume":"17","author":"Nakhaee","year":"2022","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.eclinm.2024.102517_bib66","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1345\/aph.17428","article-title":"Management of SSRI-induced sexual dysfunction","volume":"32","author":"Woodrum","year":"1998","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.eclinm.2024.102517_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104837","article-title":"Repurposing the mucolytic cough suppressant and TMPRSS2 protease inhibitor bromhexine for the prevention and management of SARS-CoV-2 infection","volume":"157","author":"Maggio","year":"2020","journal-title":"Pharmacol Res"},{"issue":"2","key":"10.1016\/j.eclinm.2024.102517_bib68","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.44942","article-title":"Efficacy of niclosamide vs placebo in SARS-CoV-2 respiratory viral clearance, viral shedding, and duration of symptoms among patients with mild to moderate COVID-19: a phase 2 randomized clinical trial","volume":"5","author":"Cairns","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102517_bib69","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-42539-7","article-title":"Assessment of safety and intranasal neutralizing antibodies of HPMC-based human anti-SARS-CoV-2 IgG1 nasal spray in healthy volunteers","volume":"13","author":"Imsuwansri","year":"2023","journal-title":"Sci Rep"},{"issue":"11","key":"10.1016\/j.eclinm.2024.102517_bib70","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1001\/jama.2020.16349","article-title":"Effect of remdesivir vs standard care on clinical status at 11 Days in patients with moderate COVID-19: a randomized clinical trial","volume":"324","author":"Spinner","year":"2020","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102517_bib71","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s12879-022-07068-0","article-title":"Efficacy of antiviral therapies for COVID-19: a systematic review of randomized controlled trials","volume":"22","author":"Vegivinti","year":"2022","journal-title":"BMC Infect Dis"},{"issue":"4","key":"10.1016\/j.eclinm.2024.102517_bib72","doi-asserted-by":"crossref","first-page":"763","DOI":"10.3390\/v14040763","article-title":"Antiviral efficacy of molnupiravir for COVID-19 treatment","volume":"14","author":"Bai","year":"2022","journal-title":"Viruses"},{"issue":"12","key":"10.1016\/j.eclinm.2024.102517_bib73","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/S1473-3099(22)00507-2","article-title":"Real-world effectiveness of early molnupiravir or nirmatrelvir\u2013ritonavir in hospitalised patients with COVID-19 without supplemental oxygen requirement on admission during Hong Kong's omicron BA.2 wave: a retrospective cohort study","volume":"22","author":"Wong","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.eclinm.2024.102517_bib74","first-page":"ciac443","article-title":"Effectiveness of paxlovid in reducing severe coronavirus disease 2019 and mortality in high-risk patients","volume":"76","author":"Najjar-Debbiny","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"48","key":"10.1016\/j.eclinm.2024.102517_bib75","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.15585\/mmwr.mm7148e2","article-title":"Paxlovid associated with decreased hospitalization rate among adults with COVID-19 - United States, April-September 2022","volume":"71","author":"Shah","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.eclinm.2024.102517_bib76","series-title":"Synthesis of essential drugs","first-page":"219","article-title":"16 - Antihistamine drugs","author":"Vardanyan","year":"2006"},{"issue":"21","key":"10.1016\/j.eclinm.2024.102517_bib77","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1001\/jama.2020.21694","article-title":"The need for more and better testing for COVID-19","volume":"324","author":"Manabe","year":"2020","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.eclinm.2024.102517_bib78","doi-asserted-by":"crossref","first-page":"e181","DOI":"10.1016\/S2214-109X(21)00568-4","article-title":"Test and treat: a missing link in the global fight against COVID-19","volume":"10","author":"Wroe","year":"2022","journal-title":"Lancet Global Health"},{"issue":"5","key":"10.1016\/j.eclinm.2024.102517_bib79","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taad096","article-title":"Tracing the transmission of mpox through wastewater surveillance in Southeast Asia","volume":"30","author":"Wannigama","year":"2023","journal-title":"J\u00a0Trav Med"},{"key":"10.1016\/j.eclinm.2024.102517_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2022.159816","article-title":"Multiple traces of monkeypox detected in non-sewered wastewater with sparse sampling from a densely populated metropolitan area in Asia","volume":"858","author":"Wannigama","year":"2023","journal-title":"Sci Total Environ"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537024000968?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537024000968?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T20:06:42Z","timestamp":1762632402000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537024000968"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":80,"alternative-id":["S2589537024000968"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2024.102517","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early treatment with fluvoxamine, bromhexine, cyproheptadine, and niclosamide to prevent clinical deterioration in patients with symptomatic COVID-19: a randomized clinical trial","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2024.102517","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102517"}}